Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Antimicrobial Peptides
100%
Sarconesiopsis Magellanica
100%
New Antimicrobials
100%
Pseudomonas Aeruginosa (P. aeruginosa)
50%
Gram-negative
50%
Minimum Inhibitory Concentration
25%
Antimicrobial Activity
25%
Health Institutions
25%
Mass Spectrometry
25%
Antibiotic Resistance
25%
Physicochemical Properties
25%
Staphylococcus Aureus
25%
Mechanism of Action
25%
Human Erythrocytes
25%
HeLa Cells
25%
Blowfly
25%
Peptide Sequencing
25%
Health Organizations
25%
Micrococcus Luteus
25%
Reversed-phase HPLC
25%
C18 Column
25%
Gram-positive
25%
Bacterial Membrane
25%
New Resources
25%
Fluorescence Microscopy
25%
ATP Synthase
25%
FLI1
25%
PA14
25%
Dangerous Level
25%
Therapeutic Candidates
25%
Multidrug-resistant Bacteria
25%
No Toxicity
25%
M. Luteus
25%
Bacterial DNA
25%
Conserved Domain
25%
Electronic Microscopy
25%
Escherichia Coli MG1655
25%
Gram-positive Bacteria
25%
Alternative Therapeutics
25%
Immunology and Microbiology
Secretion (Process)
100%
Antimicrobial Peptides
100%
Pseudomonas aeruginosa
50%
Minimum Inhibitory Concentration
25%
Escherichia coli
25%
Peptides
25%
Antimicrobial Agent
25%
Amino Acid Sequence
25%
Antimicrobial Activity
25%
Antimicrobial Resistance
25%
Staphylococcus aureus
25%
Erythrocyte
25%
Gram-Positive Bacteria
25%
Micrococcus luteus
25%
Reverse Phase High Performance Liquid Chromatography
25%
Calliphoridae
25%
Bacterial Membrane
25%
Fluorescence Microscopy
25%
Leronlimab
25%
Electron Microscopy
25%
Biochemistry, Genetics and Molecular Biology
Secretion (Process)
100%
Antimicrobial Peptides
100%
Pseudomonas aeruginosa
50%
Minimum Inhibitory Concentration
25%
Peptide Sequence
25%
High-Performance Liquid Chromatography
25%
Escherichia coli
25%
Mass Spectrometry
25%
Bacterial Membrane
25%
Antibiotic Resistance
25%
Gram Positive Bacterium
25%
Electron Microscopy
25%
Calliphoridae
25%
Micrococcus luteus
25%
ATP Synthase
25%
Antimicrobial Activity
25%
Fluorescence Microscopy
25%
Staphylococcus aureus
25%
Pharmacology, Toxicology and Pharmaceutical Science
Polypeptide Antibiotic Agent
100%
Pseudomonas aeruginosa
50%
Infection
25%
Minimum Inhibitory Concentration
25%
Antimicrobial Agent
25%
Antiinfective Agent
25%
Antimicrobial Resistance
25%
Staphylococcus aureus
25%
Escherichia coli
25%
Reverse Phase High Performance Liquid Chromatography
25%
Leronlimab
25%
Adenosine Triphosphate
25%
Gram Positive Bacterium
25%
Fluorescence Microscopy
25%
Electron Microscopy
25%
Micrococcus luteus
25%
Synthetase
25%
Calliphoridae
25%